Xeris Biopharma Holdings (XERS) Goodwill (2021 - 2025)
Historic Goodwill for Xeris Biopharma Holdings (XERS) over the last 5 years, with Q3 2025 value amounting to $22.9 million.
- Xeris Biopharma Holdings' Goodwill changed 0.0% to $22.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $22.9 million, marking a year-over-year change of 0.0%. This contributed to the annual value of $22.9 million for FY2024, which is 0.0% changed from last year.
- As of Q3 2025, Xeris Biopharma Holdings' Goodwill stood at $22.9 million, which was down 0.0% from $22.9 million recorded in Q2 2025.
- Xeris Biopharma Holdings' 5-year Goodwill high stood at $22.9 million for Q4 2021, and its period low was $22.9 million during Q4 2021.
- Over the past 5 years, Xeris Biopharma Holdings' median Goodwill value was $22.9 million (recorded in 2021), while the average stood at $22.9 million.
- Examining YoY changes over the last 5 years, Xeris Biopharma Holdings' Goodwill showed a top increase of 0.0% in 2022 and a maximum decrease of 0.0% in 2022.
- Quarter analysis of 5 years shows Xeris Biopharma Holdings' Goodwill stood at $22.9 million in 2021, then changed by 0.0% to $22.9 million in 2022, then changed by 0.0% to $22.9 million in 2023, then changed by 0.0% to $22.9 million in 2024, then changed by 0.0% to $22.9 million in 2025.
- Its last three reported values are $22.9 million in Q3 2025, $22.9 million for Q2 2025, and $22.9 million during Q1 2025.